Token导航 LogoToken导航TokenDH.com
研究检索权限需确认clawhub未标认证来源可访问clear审计通过

antibody-humanizer抗体人源化剂

Agent Skill

antibody-humanizer 用于查找、检索和筛选相关信息,适合在 OpenClaw 中需要根据关键词、任务场景或来源线索快速定位候选结果时使用。可结合来源仓库、安装命令和原始 README 继续核验具体用法。安装前建议确认权限范围、维护状态,以及是否会触发联网、命令执行或文件读写。

总安装

5,116

周安装

209

GitHub Stars

公开资料未说明

下载量

1,655
OpenClaw

安装说明

本站只整理中文说明和来源信息,不托管安装包,也不代用户安装。

GitHub

来源数

2

许可证

MIT-0

最后核验

2026-05-01

来源状态

来源可访问

安装方式

通过对话安装

复制提示词发给支持本地命令或 Skills 的 AI 助手,先确认命令和权限,再让它执行。

请帮我安装这个 Agent Skill:antibody-humanizer(抗体人源化剂)
来源仓库:https://github.com/aipoch-ai/antibody-humanizer
安装命令:
openclaw skills install antibody-humanizer
安装前请先检查当前环境是否支持对应 CLI,并向我确认将要执行的命令、安装目录、联网范围和文件读写权限;确认后再执行。

命令行安装

复制命令到本机终端执行。该命令会通过 OpenClaw 从第三方来源获取 Skill;本站只展示命令,不托管安装包,也不自动执行。

ClawHubOpenClaw
openclaw skills install antibody-humanizer

简介

antibody-humanizer 预测鼠源抗体人源化序列,降低免疫原性同时保留抗原结合能力。

  • 适用于 OpenClaw 中生物医药研发场景,支持 CDR 移植与框架优化策略。
  • 输出包含突变位点与稳定性评估的完整设计方案。
  • 使用前应确认是否涉及敏感基因数据处理,遵守相关科研伦理规范。
  • 建议结合实验验证结果迭代模型参数,提高预测准确性。

SKILL.md

name
antibody-humanizer
description
Humanize murine antibody sequences using CDR grafting and framework
allowed-tools
[Read, Write, Bash, Edit]
license
MIT
metadata
skill-author
AIPOCH

Antibody Humanizer

Overview

Bioinformatics platform for converting murine antibodies into humanized variants by grafting complementarity-determining regions (CDRs) onto human framework templates while preserving antigen-binding affinity and reducing immunogenicity risk.

Key Capabilities:

  • CDR Identification: Automatic CDR boundary detection (Kabat/Chothia/IMGT schemes)
  • Framework Matching: Database search for optimal human germline templates
  • Humanization Scoring: Multi-parameter immunogenicity risk assessment
  • Back-Mutation Prediction: Identify critical framework residues for retention
  • Batch Processing: Humanize multiple antibody candidates efficiently
  • Immunogenicity Assessment: T-cell epitope and humanness scoring

When to Use

✅ Use this skill when:

  • Converting murine hybridoma antibodies to therapeutic candidates
  • Reducing immunogenicity risk of rodent-derived antibodies
  • Selecting human framework templates for CDR grafting
  • Identifying critical framework residues for antigen binding
  • Comparing multiple humanization strategies for lead optimization
  • Preparing antibody sequences for patent filings
  • Teaching antibody engineering principles

❌ Do NOT use when:

  • Fully human antibody generation from phage display → Use phage-display-library
  • De novo antibody design → Use antibody-design-ai
  • Affinity maturation → Use affinity-maturation-predictor
  • ADCC/CDC optimization → Use fc-engineering-toolkit
  • Final therapeutic candidate selection → Requires experimental validation

Integration:

  • Upstream: antibody-sequencer (VH/VL sequence determination), cdr-grafting-validator (structural assessment)
  • Downstream: protein-struct-viz (3D visualization), immunogenicity-predictor (T-cell epitope analysis)

Core Capabilities

1. CDR Region Identification

Parse antibody sequences and identify CDR boundaries:

from scripts.humanizer import AntibodyHumanizer

humanizer = AntibodyHumanizer()

# Analyze antibody sequence
analysis = humanizer.analyze_sequence(
    vh_sequence="QVQLQQSGPELVKPGASVKISCKASGYTFTDYYMHWVKQSHGKSLEWIGYINPSTGYTEYNQKFKDKATLTVDKSSSTAYMQLSSLTSEDSAVYYCAR...",
    vl_sequence="DIQMTQSPSSLSASVGDRVTITCRASQGISSWLAWYQQKPGKAPKLLIYKASSLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYSSYPYT...",
    scheme="chothia"  # Options: kabat, chothia, imgt
)

# Output CDR locations
print(analysis.cdr_regions)
# {
#   "VH_CDR1": {"start": 26, "end": 32, "seq": "GYTFTDY"},
#   "VH_CDR2": {"start": 52, "end": 58, "seq": "INPSTGY"},
#   ...
# }

Numbering Schemes:

SchemeVH CDR1VH CDR2VH CDR3Best For
Chothia26-3252-5695-102Structural analysis
Kabat31-3550-6595-102Sequence-based work
IMGT27-3856-65105-117Standardized analysis

2. Human Framework Matching

Identify optimal human germline templates:

# Match against human germline database
matches = humanizer.find_human_frameworks(
    vh_framework=analysis.vh_frameworks,
    vl_framework=analysis.vl_frameworks,
    top_n=5,
    criteria=["homology", "canonical_structure", "vernier_similarity"]
)

# Evaluate each candidate
for match in matches:
    print(f"Template: {match.germline_genes}")
    print(f"Homology: {match.homology:.2%}")
    print(f"Vernier Score: {match.vernier_score:.1f}")
    print(f"Risk Level: {match.immunogenicity_risk}")

Matching Criteria:

  • Sequence Homology: Percent identity to human germline
  • Canonical Structure: Loop conformation compatibility
  • Vernier Region: Framework residues contacting CDRs
  • Interface Residues: Packing interactions with CDRs

3. Humanization Scoring

Assess immunogenicity risk of candidates:

# Score humanization candidates
scores = humanizer.score_candidates(
    murine_antibody=analysis,
    human_templates=matches,
    scoring_methods=["t20", "h_score", "germline_deviation", "paratope_diversity"]
)

# Rank by overall score
ranked = scores.rank_by_composite_score(
    weights={"humanness": 0.4, "binding_retention": 0.4, "developability": 0.2}
)

Scoring Methods:

MethodDescriptionTarget
T20 Score20-mer peptide humanization>80% human
H-ScoreHummerblind germline distance<15 mutations
Paratope DiversityCDR germline gene diversityLow diversity
DevelopabilityAggregation/pH stability predictionHigh score

4. Back-Mutation Prediction

Identify critical residues to retain from murine framework:

# Predict back-mutations
back_mutations = humanizer.predict_back_mutations(
    murine_vh=analysis.vh_sequence,
    human_vh=matches[0].human_template,
    cdr_regions=analysis.cdr_regions,
    rationale_required=True
)

# Output shows position-specific recommendations
for mutation in back_mutations:
    print(f"Position {mutation.position}: {mutation.human_aa} → {mutation.murine_aa}")
    print(f"Rationale: {mutation.reason}")  # e.g., "Vernier region contact"
    print(f"Priority: {mutation.priority}")  # Critical/Important/Optional

Critical Residue Classes:

  • Vernier Positions: Framework residues contacting CDRs (VH 24, 71, 94)
  • Interface Packs: Residue packing between VH and VL
  • Canonical Anchors: Cysteines and conserved framework positions
  • Buried Positions: Core packing residues affecting stability

Common Patterns

Pattern 1: Standard Therapeutic Humanization

Scenario: Convert murine anti-tumor antibody to therapeutic candidate.

# Humanize single antibody
python scripts/main.py \
  --vh "QVQLQQSGPELVKPGASVKISCKAS..." \
  --vl "DIQMTQSPSSLSASVGDRVTITCRAS..." \
  --name "Anti-HER2-Murine-1" \
  --scheme chothia \
  --top-n 3 \
  --output humanization_report.json

# Review top candidates
cat humanization_report.json | jq '.candidates[0]'

Workflow:

  1. Input murine VH/VL sequences
  2. Identify CDRs using Chothia scheme
  3. Match to human germline database
  4. Score top 3 candidates
  5. Identify required back-mutations
  6. Output humanized sequences

Pattern 2: Batch Humanization Screening

Scenario: Screen multiple murine clones from hybridoma campaign.

# Process multiple antibodies
antibodies = [
    {"name": "Clone-A", "vh": "...", "vl": "..."},
    {"name": "Clone-B", "vh": "...", "vl": "..."},
    {"name": "Clone-C", "vh": "...", "vl": "..."}
]

results = humanizer.batch_humanize(
    antibodies=antibodies,
    ranking_criteria="composite_score",
    min_humanness=0.85
)

# Rank by developability
ranked = results.rank_by(criteria=["humanness", "binding_retention", "stability"])

Selection Criteria:

  • Highest humanness score (>85%)
  • Fewest back-mutations required (<6)
  • Low immunogenicity risk
  • Good developability profile

Pattern 3: Framework Template Comparison

Scenario: Compare different humanization strategies for lead candidate.

# Test multiple framework combinations
strategies = [
    {"vh": "IGHV1-2*02", "vl": "IGKV1-12*01", "name": "Template-A"},
    {"vh": "IGHV3-23*01", "vl": "IGKV3-20*01", "name": "Template-B"},
    {"vh": "IGHV4-34*01", "vl": "IGKV1-5*01", "name": "Template-C"}
]

comparison = humanizer.compare_strategies(
    murine_antibody=analysis,
    strategies=strategies,
    metrics=["homology", "back_mutations", "immunogenicity", "paratope_structure"]
)

comparison.generate_report("framework_comparison.pdf")

Comparison Metrics:

  • Sequence identity to human germline
  • Number and location of back-mutations
  • Predicted immunogenicity risk
  • CDR conformation preservation

Pattern 4: Intellectual Property Analysis

Scenario: Assess humanization for patent landscape analysis.

# Generate humanized variants
python scripts/main.py \
  --input murine_lead.json \
  --generate-variants 10 \
  --include-back-mutations \
  --output variants_for_ip.json

# Check novelty against patent databases
python scripts/patent_check.py \
  --sequences variants_for_ip.json \
  --databases [USPTO, EPO, WIPO] \
  --output novelty_report.pdf

IP Considerations:

  • Human framework combinations may be patented
  • CDR sequences determine antigen specificity
  • Back-mutation positions may be prior art
  • Document humanization rationale for filings

Complete Workflow Example

From murine hybridoma to therapeutic candidate:

# Step 1: Sequence analysis and CDR identification
python scripts/main.py \
  --vh $VH_SEQUENCE \
  --vl $VL_SEQUENCE \
  --scheme chothia \
  --output step1_analysis.json

# Step 2: Find best human frameworks
python scripts/main.py \
  --input step1_analysis.json \
  --find-frameworks \
  --top-n 5 \
  --output step2_frameworks.json

# Step 3: Score and rank candidates
python scripts/main.py \
  --input step2_frameworks.json \
  --score-candidates \
  --include-immunogenicity \
  --output step3_scored.json

# Step 4: Predict back-mutations
python scripts/main.py \
  --input step3_scored.json \
  --predict-back-mutations \
  --rationale \
  --output step4_backmutations.json

# Step 5: Generate final humanized sequences
python scripts/main.py \
  --input step4_backmutations.json \
  --generate-sequences \
  --format fasta \
  --output humanized_antibody.fasta

Python API:

from scripts.humanizer import AntibodyHumanizer
from scripts.scoring import HumanizationScorer
from scripts.backmutation import BackMutationPredictor

# Initialize pipeline
humanizer = AntibodyHumanizer()
scorer = HumanizationScorer()
bm_predictor = BackMutationPredictor()

# Step 1: Parse and analyze
antibody = humanizer.analyze_sequence(
    vh_sequence=murine_vh,
    vl_sequence=murine_vl,
    scheme="chothia"
)

# Step 2: Find human frameworks
candidates = humanizer.find_human_frameworks(
    antibody,
    top_n=5
)

# Step 3: Score candidates
for candidate in candidates:
    scores = scorer.calculate_scores(
        murine=antibody,
        humanized=candidate
    )
    candidate.composite_score = scores.weighted_score()

# Step 4: Select best and predict back-mutations
best = max(candidates, key=lambda x: x.composite_score)
back_mutations = bm_predictor.predict(
    murine=antibody,
    human_template=best
)

# Step 5: Generate final sequence
final_sequence = humanizer.generate_humanized_sequence(
    template=best,
    back_mutations=back_mutations,
    cdrs=antibody.cdr_regions
)

print(f"Humanized antibody generated:")
print(f"- Humanness: {best.humanness:.1%}")
print(f"- Back-mutations: {len(back_mutations)}")
print(f"- Risk level: {best.immunogenicity_risk}")

Quality Checklist

Input Quality:

  • [ ] VH and VL sequences complete (110-130 aa typical)
  • [ ] No ambiguous residues (B, Z, X)
  • [ ] Signal peptide removed
  • [ ] Constant region removed (variable region only)

Humanization Assessment:

  • [ ] CDR boundaries correctly identified
  • [ ] Human framework homology >80%
  • [ ] T20 score >75 (high humanness)
  • [ ] Vernier positions analyzed for back-mutations
  • [ ] Interface residues checked for packing

Output Validation:

  • [ ] Humanized sequence valid (no stop codons)
  • [ ] CDRs preserved exactly
  • [ ] Framework length conserved
  • [ ] Back-mutations documented with rationale
  • [ ] CRITICAL: Immunogenicity risk assessed

Before Experimental Work:

  • [ ] CRITICAL: Top 2-3 candidates selected for expression
  • [ ] Binding affinity to be tested (ELISA/Biacore)
  • [ ] Stability assessed (thermal/aggregation)
  • [ ] Immunogenicity in vitro assays planned

Common Pitfalls

Sequence Issues:

  • Incomplete sequences → Missing framework regions

- ✅ Ensure full VH/VL variable domains provided

  • Wrong numbering scheme → CDR boundaries incorrect

- ✅ Verify scheme matches experimental data source

  • Non-standard residues → Unusual amino acids

- ✅ Clean sequences; remove signal peptides

Design Issues:

  • Over-humanization → Losing antigen binding

- ✅ Don't exceed 85-90% humanness; retain critical residues

  • Ignoring back-mutations → Assuming 100% human framework works

- ✅ Always predict and test back-mutations

  • Single candidate only → No backup options

- ✅ Generate 2-3 candidates with different frameworks

Experimental Issues:

  • Skipping binding validation → Assuming in silico = in vivo

- ✅ Always confirm antigen binding experimentally

  • Ignoring developability → Aggregation or instability

- ✅ Check for problematic residues (unpaired cysteines, hydrophobic patches)

References

Available in references/ directory:

  • imgt_germline_database.md - Human germline gene reference sequences
  • cdr_numbering_schemes.md - Kabat, Chothia, IMGT comparison
  • humanization_case_studies.md - Successful therapeutic examples
  • vernier_positions_guide.md - Critical framework residues
  • immunogenicity_assessment.md - T-cell epitope prediction methods
  • patent_landscape.md - Humanization IP considerations

Scripts

Located in scripts/ directory:

  • main.py - CLI interface for humanization
  • humanizer.py - Core humanization engine
  • cdr_parser.py - CDR identification and numbering
  • framework_matcher.py - Human germline database search
  • scoring.py - Humanization quality assessment
  • backmutation.py - Critical residue prediction
  • batch_processor.py - Multiple antibody screening
  • structure_predictor.py - CDR conformation analysis

Limitations

  • Binding Prediction: Cannot accurately predict impact on antigen affinity
  • Developability: Limited prediction of aggregation or stability issues
  • Immunogenicity: In silico T-cell epitope prediction has false positives
  • Non-Standard Antibodies: May not handle camelid, shark, or engineered scaffolds
  • Experimental Validation Required: All predictions must be confirmed in vitro/vivo
  • Intellectual Property: Does not check for existing patent claims on sequences

Parameters

ParameterTypeDefaultRequiredDescription
--vhstring-NoMurine VH sequence (amino acids)
--vlstring-NoMurine VL sequence (amino acids)
--input, -istring-NoInput JSON file path
--name, -nstring""NoAntibody name
--output, -ostring-NoOutput file path
--format, -fstringjsonNoOutput format (json, fasta, csv)
--scheme, -sstringchothiaNoNumbering scheme (kabat, chothia, imgt)
--top-nint3NoNumber of best candidates to return

Usage

Basic Usage

# Humanize with direct sequence input
python scripts/main.py --vh "QVQLQQSGPELVKPGASVKMSCKAS..." --vl "DIQMTQSPSSLSASVGDRVTITC..." --name "MyAntibody"

# Use JSON input file
python scripts/main.py --input antibody.json --output results.json

# Use IMGT numbering scheme
python scripts/main.py --vh "SEQUENCE" --vl "SEQUENCE" --scheme imgt

Input JSON Format

{
  "vh_sequence": "QVQLQQSGPELVKPGASVKMSCKAS...",
  "vl_sequence": "DIQMTQSPSSLSASVGDRVTITC...",
  "name": "MyAntibody",
  "scheme": "chothia"
}

Risk Assessment

Risk IndicatorAssessmentLevel
Code ExecutionPython script executed locallyMedium
Network AccessNo external API callsLow
File System AccessRead input files, write output filesLow
Instruction TamperingStandard prompt guidelinesLow
Data ExposureOutput may contain proprietary sequencesMedium

Security Checklist

  • [x] No hardcoded credentials or API keys
  • [x] No unauthorized file system access (../)
  • [x] Input validation for sequences
  • [x] Prompt injection protections in place
  • [x] Error messages sanitized
  • [x] Output directory restricted to workspace
  • [x] Script execution in sandboxed environment

Prerequisites

# Python 3.7+
# No external packages required (uses standard library)

Evaluation Criteria

Success Metrics

  • [x] Successfully parses antibody sequences
  • [x] Identifies CDR regions correctly
  • [x] Matches human germline frameworks
  • [x] Predicts back-mutations
  • [x] Generates valid humanized sequences

Test Cases

  1. Basic Functionality: Humanize valid VH/VL sequences → Returns candidates
  2. Edge Case: Invalid sequence characters → Graceful error message
  3. File Input: Process JSON input → Correctly parses and outputs

Lifecycle Status

  • Current Stage: Draft
  • Next Review Date: 2026-03-06
  • Known Issues: None
  • Planned Improvements:

- Add T20 score database integration - Support for camelid and shark antibodies - Structure-based CDR prediction


🔬 Critical Note: Computational humanization is a design tool, not a substitute for experimental validation. Always express and test humanized candidates for binding affinity, specificity, stability, and immunogenicity before therapeutic development.

适合场景

01

OpenClaw 用户查找和安装 Skill 时

02

用户想查找某类 Agent Skill 时

03

需要根据任务场景推荐可安装能力包时

04

需要对比不同来源的安装命令和来源信息时

能力概览

能力 1

按任务关键词查找相关 Skills

能力 2

展示可复制的安装命令

能力 3

保留来源站点、仓库和原始说明,方便继续核验

能力 4

补充不同宿主或平台的使用分布数据

能力 5

展示第三方安全扫描或审计结果

安装后应在对应宿主中按原始 README 的触发条件使用;具体调用方式请以来源页面和 README 为准。

平台分布

OpenClaw

96.95%
按下载量换算1,605

安全审计

VirusTotal

通过

ClawScan

通过

Static analysis

通过

权限和风险

权限需确认

当前来源未能明确判断权限范围,默认进入异常复核队列。

安装前确认

本站仅展示第三方公开信息,不托管安装包,不提供自动安装或运行环境。安装前应自行审查源码、依赖和命令行为。当前只有一个来源,正式发布前建议补源仓库或其他目录站核验。

来源信息

继续浏览同类 Skills